Shlomai A[au] - Search Results

Year	Number of Results
2001	2
2003	1
2004	2
2006	1
2008	1
2009	2
2010	5
2011	5
2012	8
2013	5
2014	3
2015	5
2016	5
2017	5
2018	9
2019	5
2020	8
2021	7
2022	3

1

Acute liver failure is regulated by MYC- and microbiome-dependent programs.

Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-Bachash M, Hornstein S, Leshem A, Reuveni D, Zigmond E, Tobar A, Salame TM, Harmelin A, Shlomai A, Shapiro H, Amit I, Elinav E. Kolodziejczyk AA, et al. Among authors: shlomai a. Nat Med. 2020 Dec;26(12):1899-1911. doi: 10.1038/s41591-020-1102-2. Epub 2020 Oct 26. Nat Med. 2020. PMID: 33106666

2

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Taylor RS, Taylor RJ, Bayliss S, Hagström H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, Shlomai A, Sebastiani G, Seko Y, Bhala N, Younossi ZM, Anstee QM, McPherson S, Newsome PN. Taylor RS, et al. Among authors: shlomai a. Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4. Gastroenterology. 2020. PMID: 32027911 Free article.

3

Early post-liver transplantation infections and their effect on long-term survival.

Leibovici-Weissman Y, Anchel N, Nesher E, Leshno M, Shlomai A. Leibovici-Weissman Y, et al. Among authors: shlomai a. Transpl Infect Dis. 2021 Aug;23(4):e13673. doi: 10.1111/tid.13673. Epub 2021 Jul 9. Transpl Infect Dis. 2021. PMID: 34153169

4

New therapies for chronic hepatitis B.

Bitton Alaluf M, Shlomai A. Bitton Alaluf M, et al. Among authors: shlomai a. Liver Int. 2016 Jun;36(6):775-82. doi: 10.1111/liv.13086. Epub 2016 Mar 14. Liver Int. 2016. PMID: 26854115 Review.

5

Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis.

Shlomai A, Leshno M, Goldstein DA. Shlomai A, et al. Therap Adv Gastroenterol. 2019 Sep 23;12:1756284819878304. doi: 10.1177/1756284819878304. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31579104 Free PMC article.

6

Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis.

Shlomai A, Leshno A, Sklan EH, Leshno M. Shlomai A, et al. Value Health. 2021 May;24(5):607-614. doi: 10.1016/j.jval.2020.09.013. Epub 2020 Dec 9. Value Health. 2021. PMID: 33933228 Free PMC article.

7

Ectopic splenomegaly.

Shlomai A, Guzner-Gur H. Shlomai A, et al. Intern Med J. 2010 Aug;40(8):600. doi: 10.1111/j.1445-5994.2010.02302.x. Intern Med J. 2010. PMID: 20718886 No abstract available.

8

Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.

Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Shafran N, et al. Among authors: shlomai a. JHEP Rep. 2021 Jun;3(3):100258. doi: 10.1016/j.jhepr.2021.100258. Epub 2021 Feb 24. JHEP Rep. 2021. PMID: 33644724 Free PMC article.

9

A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel.

Goldberg E, Ben Zvi H, Sheena L, Sofer S, Krause I, Sklan EH, Shlomai A. Goldberg E, et al. Among authors: shlomai a. Clin Microbiol Infect. 2021 Jun;27(6):917.e1-917.e4. doi: 10.1016/j.cmi.2021.02.029. Epub 2021 Mar 9. Clin Microbiol Infect. 2021. PMID: 33705849 Free PMC article.

10

Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients.

Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, Shlomai A, Goldberg E, Sklan EH. Shafran N, et al. Among authors: shlomai a. Sci Rep. 2021 Jun 16;11(1):12703. doi: 10.1038/s41598-021-92220-0. Sci Rep. 2021. PMID: 34135459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results